


OncoRNA
Pharmaceutical Manufacturing • Charleroi, Walloon Region, Belgium • 1-10 Employees
Company overview
| Headquarters | Rue Louis Breguet 1, Charleroi, Walloon Region 6041, BE |
| Website | |
| NAICS | 3254 |
| Keywords | RNA, Vaccines, Cancers |
| Founded | 2023 |
| Employees | 1-10 |
Key Contact at OncoRNA
Christophe Van Huffel
Co-Founder and CSO
About OncoRNA
OncoRNA SA is a subsidiary of OncoDNA SA, a leading genomics and theranostics company focused on precision medicine for cancer and genetic diseases. Our mission of OncoRNA is to manufacture and commercialize Personalized RNA Cancer Immuno-Therapy (PRCIT) potentially a fast, high-performant, and cost-effective personalized immunotherapies for cancer patients. Our therapy utilizes a proprietary technology that combines small neoantigen mRNA (snmRNA) pool technology with lipid nanoparticle (LNP) technology, enabling the design of personalized mRNA cancer vaccines. By stimulating the patient's immune system to target and eliminate tumor cells based on specific mutations, OncoRNA's PRCIT offers a groundbreaking approach to cancer immunotherapy.
OncoRNA revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OncoRNA has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
OncoRNA has never raised funding before.
OncoRNA Tech Stack
Discover the technologies and tools that power OncoRNA's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Analytics
Maps
UI frameworks
JavaScript libraries
Page builders
JavaScript libraries
Programming languages
Blogs
Analytics
UI frameworks
Frequently asked questions
4.8
40,000 users



